guanabenz has been researched along with nadp in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Clement, B; Demesmaeker, M; Linne, S | 1 |
| Dambrova, M; Uhlén, S; Wikberg, JE | 1 |
2 other study(ies) available for guanabenz and nadp
| Article | Year |
|---|---|
Microsomal catalyzed N-hydroxylation of guanabenz and reduction of the N-hydroxylated metabolite: characterization of the two reactions and genotoxic potential of guanoxabenz.
Topics: Adrenergic alpha-Agonists; Animals; Antihypertensive Agents; Chromatography, High Pressure Liquid; Cytochrome P-450 Enzyme System; Female; Guanabenz; Humans; Hydroxylation; Inactivation, Metabolic; Male; Mass Spectrometry; Microsomes, Liver; Mutagenicity Tests; NAD; NADP; NADPH-Ferrihemoprotein Reductase; Oxidation-Reduction; Rabbits; Spectrophotometry, Ultraviolet; Swine | 1996 |
Characterization of guanoxabenz reducing activity in rat brain.
Topics: Allopurinol; Animals; Antihypertensive Agents; Binding, Competitive; Cerebral Cortex; Chromatography, High Pressure Liquid; Enzyme Inhibitors; Guanabenz; Male; NAD; NADP; Oxidation-Reduction; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, alpha-2; Synaptic Membranes; Xanthine | 1998 |